Profusa and Partners Announce DARPA-Backed Study to Measure Early Signs of Influenza Biodetection March 11, 2020 …
Soligenix Announces Successful Demonstration of Heat Stabilization for Filovirus Vaccine Platform Medical Countermeasures March 3, 2020 …
CureVac CEO Discusses Coronavirus Vaccine Development with White House Leadership Medical Countermeasures March 3, 2020 …
Columbia University Researchers Awarded $2M to Identify Antiviral Drugs for Coronavirus Medical Countermeasures February 21, 2020 …
Synedgen to Present Data on Therapeutic for Ocular Mustard Gas Injury at NIH Meeting CBRNE February 19, 2020 …
Humanetics Corporation Acquires Manufacturing Assets for Radioprotectant Drug CBRNE February 19, 2020 …
FDA Grants Soligenix “Fast Track” Designation for RiVax® in the Prevention of Ricin Poisoning Medical Countermeasures February 16, 2020 …
Emory, Collaborators Testing Antiviral Drug as Potential Treatment for Coronaviruses Medical Countermeasures February 15, 2020 …
Scientists from Noblis and DoD Identify Unique Genetic Sequences of Emerging Coronavirus Threat Pathogens February 13, 2020 …
Vir Biotechnology Identifies Two Antibodies That Bind to the Spike Protein of SARS-CoV-2 Medical Countermeasures February 12, 2020 …
Center for Health Security Announces Emerging Leaders in Biosecurity Initiative Class of 2020 February 11, 2020 …
Spero Therapeutics Announces Exercise of $15.9 Million Option by BARDA for Tebipenem HBr Development Antimicrobial Resistance February 7, 2020 …
Insilico Medicine Publishes Molecular Structures for Key Protein Target of SARS-CoV-2 Medical Countermeasures February 6, 2020 …